ARTICLE | Clinical News
Zorblisa regulatory update
August 17, 2015 7:00 AM UTC
Scioderm said it will begin submitting a rolling NDA to FDA this quarter for Zorblisa to treat epidermolysis bullosa. The company said it will submit the non-clinical components of the application thi...